Product Code: QGL FDA class 2 21 CFR 882.5898

Transcutaneous Nerve Stimulator For Adhd

Neurology

The Transcutaneous Nerve Stimulator For ADHD is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead to treat Attention Deficit Hyperactivity Disorder (ADHD) symptoms through targeted nerve stimulation. It is classified as FDA Class 2, requiring 510(k) premarket notification under regulation 882.5898 in the Neurology specialty. The product code is QGL. It is not an implant and is not life-sustaining.

510(k)s
5
FEI Numbers
4
Registration Numbers
4
Unique Applicants
3
Years Active
6

Research product code QGL in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
QGL
Device Class
FDA class 2
Regulation Number
882.5898
Medical Specialty
Neurology
Review Panel
NE
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 5 510(k) clearances via K numbers.

K Number Device Name
K243289 ADDNOX (BPSPM1)
K232991 BT-1000
K233293 Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®
K213629 SMILE
DEN180041 Monarch eTNS System

FEI Numbers

This FDA classification entry is associated with 4 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 4 registration numbers. Click on an entry to view related FDA registrations.